Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line teratment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice

M (Michel) van Agthoven, S Wittebol, LM (Leo) Budel, Carin Uyl - de Groot, MHH Kramer

Research output: Contribution to journalArticleAcademic

Original languageUndefined/Unknown
Pages (from-to)88-93
Number of pages6
JournalNederlands Tijdschrift voor Geneeskunde
Volume148
Publication statusPublished - 2004

Research programs

  • EMC NIHES-05-63-02 Quality

Cite this